Wolff C, Armas R, Puig A, Krause P, Parraguez A
Departamento de Medicina, Facultad de Medicina (Campus Occidente) Universidad de Chile, Hospital San Juan de Dios, Santiago de Chile.
Rev Med Chil. 1994 Mar;122(3):294-8.
Hepatitis C virus antibodies were studied in sera coming from 39 patients with porphyria (cutanea tarda in 17, variegate in 8, intermittent acute in 4, coproporphyria in 2 and protoporphyria in 8). Nine of 17 patients with porphyria cutanea tarda had positive antibodies, but none of the patients with other types of porphyria. All subjects with porphyria cutanea tarda had histological or laboratory liver abnormalities. There was no relationship between the presence of antibodies and frequency of alcoholism, diabetes, or carbohydrate intolerance. Family background of porphyria was significantly less frequent among patients with positive hepatitis C virus antibodies. In 13 patients, a liver biopsy was performed, always showing signs of chronic hepatitis, whose magnitude was higher in those with positive antibodies. It is concluded that, as reported previously, hepatitis C virus may be an activating factor for porphyria cutanea tarda or may potentiate its accompanying liver disease.
对39例卟啉病患者(迟发性皮肤卟啉病17例、混合型卟啉病8例、间歇性急性卟啉病4例、粪卟啉病2例、原卟啉病8例)的血清进行了丙型肝炎病毒抗体研究。17例迟发性皮肤卟啉病患者中有9例抗体呈阳性,但其他类型卟啉病患者中无一例阳性。所有迟发性皮肤卟啉病患者均有组织学或实验室检查提示的肝脏异常。抗体的存在与酗酒、糖尿病或碳水化合物不耐受的发生率之间无相关性。丙型肝炎病毒抗体阳性患者中卟啉病家族背景的发生率显著较低。对13例患者进行了肝活检,均显示慢性肝炎征象,抗体阳性者病变程度更高。结论是,如先前报道,丙型肝炎病毒可能是迟发性皮肤卟啉病的激活因子,或可能加重其伴发的肝脏疾病。